Вирусы и эпидемии в истории мира. Прошлое, настоящее и будущее

30. Peden, A., L. McCardle, M. W. Head, S. Love, H. J. T. Ward, S. N. Cousens, D. M. Keeling, C. M. Millar, F. G. H. Hill, and J. W. Ironside. “Variant CJD Infection in the Spleen of a Neurologically Asymptomatic UK Adult Patient with Haemophilia.” Haemophilia 16 (2010): 296–304.

31. Llewelyn, C. A., P. E. Hewitt, R. S. Knight, K. Amar, S. Cousens, J. Mackenzie, and R. G. Will. “Possible Transmission of Variant Creutzfeldt– Jakob Disease by Blood Transfusion.” Lancet 363 (2004): 417–21.

32. Lefrere, J. J., and P. Hewitt. “From Mad Cows to Sensible Blood Transfusion: The Risk of Prion Transmission by Labile Blood Components in the United Kingdom and in France.” Transfusion 49 (2009): 797–812.

33. Saborio, G. P., B. Permanne, and C. Soto. “Sensitive Detection of Pathological Prion Protein by Cyclic Amplification of Protein Misfolding.” Nature 411 (2001): 810–13.

34. Peden, A. H., M. W. Head, D. L. Ritchie, J. E. Bell, and J. W. Ironside. “Preclinical vCJD after Blood Transfusion in a PRNP Codon 129 Heterozygous Patient.” Lancet 364 (2004): 527–29.

35. Edgeworth, J. A., M. Farmer, A. Sicilia, P. Tavares, J. Beck, T. Campbell, J. Lowe, et al. “Detection of Prion Infection in Variant Creutzfeldt– Jakob Disease: A Blood– Based Assay.” Lancet 377 (2011): 487–93.

36. Jackson, G. S., J. Burk– Rafel, J. A. Edgeworth, A. Sicilia, S. Abdilahi, J. Korteweg, J. Mackey, et al. “A Highly Specific Blood Test for vCJD.” Blood 123 (2014): 452–53.

37. Collinge, J., J. Whitfield, E. McKintosh, J. Beck, S. Mead, D. J. Thomas, and M. P. Alpers. “Kuru in the 21st Century– An Acquired Human Prion Disease with Very Long Incubation Periods.” Lancet 346 (2006): 2068–74.

38. Palmer, M. S., A. J. Dryden, J. T. Hughes, and J. Collinge. “Homozygous Prion Protein Genotype Predisposes to Sporadic Creutzfeldt– Jackob Disease.” Nature 352 (1991): 340–42.

39. Mead, S., M. P. Stumpf, J. Whitfield, J. A. Beck, M. Poulter, T. Campbell, J. B. Uphill, et al. “Balancing Selection at the Prion Protein Gene Consistent with Prehistoric Kurulike Epidemics.” Science 300 (2003): 640–43.

40. Lewis, P. A., M. H. Tattum, S. Jones, D. Bhelt, M. Batchelor, A. R. Clarke, J. Collinge, and G. S. Jackson. “Codon 129 Polymorphism of the Human Prion Protein Influences the Kinetics of Amyloid Formation.” Journal of General Virology 87 (2006): 2443–49.

41. Prusiner, S. “Novel Proteinaceous Infectious Particles Cause Scrapie.” Science 216 (1982): 136–44.

42. Tahiri– Alaoui, A., A. C. Gill, P. Disterer, and W. James. “Methionine 129 Variant of Human Prion Protein Oligomerizes More Rapidly than the Valine 129 Variant: Implications for Disease Susceptibility to Creutzfeldt– Jacob Disease.” Journal of Biological Chemistry 279 (2004): 31390–97.

43. Baskakov, I., P. Disterer, L. Breydo, M. Shaw, A. Gill, W. James, and A. Tahiri– Alaoui. “The Presence of Valine at Residue 129 in Human Prion Protein Accelerates Amyloid Formation.” FEBS Letters 579 (2005): 2589–96.

44. Lasmezasi, C., P. Deslyn, R. Demaimay, K. Adjou, F. Lamoury, D. Dormount, O. Robain, J. Ironside, and J. Hauw. “BSE Transmission to Macaques.” Nature 381 (1996): 743–44.

45. Aguzzi, A., and C. Weissmann. “A Suspicious Signature.” Nature 383 (1996): 666–67.

46. O’Brien, C. “Protein Test Favors BSE – CJD Link.” Science 274 (1996): 721.

47. Collinge, J., K. Sidle, J. Meads, J. Ironside, and A. Hill. “Molecular Analysis of Prion Strain Variation and the Aetiology of ‘New Variant’ CJD.” Nature 383 (1996): 685–90.

48. McNeil, D. G., Jr. “US Reduces Testing for Mad Cow Disease, Citing Few Infections.” New York Times, July 21, 2006.

49. Stocklow, S. “US Falls Behind in Tracking Cattle to Control Disease.” Wall Street Journal, June 21, 2006.

50. Institute of Medicine, National Academy of Sciences. Advancing Prion Science: Guidance for the National Prion Research Program. Washington, DC: National Academies Press, 2003.

51. “Creekstone Farms to Pursue Right to Test for Mad Cow Disease Despite USDA Opposition.” Progressive Grocer, June 1, 2007.

52. “BSE.” World Health Organization, 2002. https://www.cdc.gov/ prions/bse.

53. Williams, E. S., and S. Young. “Chronic Wasting Disease of Captive Mule Deer: A Spongiform Encephalopathy.” Journal of Wildlife Diseases 16 (1980): 89–98.

54. Williams, E. S., and S. Young. “Spongiform Encephalopathy of Rocky Mountain Elk.” Journal of Wildlife Diseases 18 (1982): 465–71.

55. Williams, E. S., and M. W. Miller. “Chronic Wasting Disease in Deer and Elk in North America.” Revue Scientifique et Technique 21 (2002): 305–16.

56. McWhirter, C. “Fears Rise about Fatal Deer Illness.” Wall Street Journal, February 8, 2019.